ConceptSet

Abatacept, Drug Exposure


Variable Name

rx_abatacept

Refreshed Date

2020-03

Files

1 Download↓
rx_2020_03_Abatacept_V1.csv (7.24 KB)
↓

Tags

Level of Review

Data Model

Vocabularies


This concept set was intended to identify Abatacept exposures among pediatric nephrology cohorts such as Glomerular Disease or Membranoproliferative Glomerulonephritis (MPGN).


Variable Status

Funder(s)

Provenance

This concept set was developed for the Membranoproliferative Glomerulonephritis (MPGN) in PEDSnet study.

Description

This concept set contains codes pertaining to the medication abatacept. It was developed by authors of Denburg et. al., 2019 (DOI: 10.1681/ASN.2019040365), including Michelle Denburg (clinician), Hanieh Razzaghi (data scientist/informaticist) and Charles Bailey (clinician/informaticist).

Please note: As this concept set was developed five years ago, it should be reviewed and updated prior to reuse in any further studies. Furthermore it is not at the Semantic Clinical Drug Form/Semantic Clinical Drug Group level so does not adhere to current best practices within PEDSnet.

Medication Term Classes






Clinical Subjects Headings

Development Code

Study Variable Applications

Membranoproliferative Glomerulonephritis (MPGN) in PEDSnet
Study Dates:2019-06 - 2026-07Sponsor Site:Children's Hospital of Philadelphia
Project to identify and conduct phenotypic characterization of children with C3G and IC-MPGN in PEDSnet using data science and chart review methods. The long-term goal of this work is to perform a large multi-institutional natural history study, compare clinical outcomes in C3G and IC-MPGN, and identify predictors of disease response or progression.

Published Research Applications

Using Electronic Health Record Data to Rapidly Identify Children with Glomerular Disease for Clinical Research
Published:2019-11-15Journal:JASN
**Significance Statement**
Clinical advances in glomerular disease have been stymied by the rarity of these health conditions, making identification of sufficient numbers of patients with glomerular disease for enrollment in research studies challenging, particularly in the pediatric setting. We leveraged the PEDSnet pediatric health system population of >6.5 million children to develop and evaluate a highly sensitive and specific electronic health record (EHR)–based computable phenotype algorithm to identify the largest cohort of children with glomerular disease to date. This tool for rapid cohort identification applied to a robust resource of multi-institutional longitudinal EHR data offers great potential to enhance and accelerate comparative effectiveness and health outcomes research in glomerular disease. **Background**
The rarity of pediatric glomerular disease makes it difficult to identify sufficient numbers of participants for clinical trials. This leaves limited data to guide improvements in care for these patients. **Methods**
The authors developed and tested an electronic health record (EHR) algorithm to identify children with glomerular disease. We used EHR data from 231 patients with glomerular disorders at a single center to develop a computerized algorithm comprising diagnosis, kidney biopsy, and transplant procedure codes. The algorithm was tested using PEDSnet, a national network of eight children’s hospitals with data on >6.5 million children. Patients with three or more nephrologist encounters (n=55,560) not meeting the computable phenotype definition of glomerular disease were defined as nonglomerular cases. A reviewer blinded to case status used a standardized form to review random samples of cases (n=800) and nonglomerular cases (n=798). **Results**
The final algorithm consisted of two or more diagnosis codes from a qualifying list or one diagnosis code and a pretransplant biopsy. Performance characteristics among the population with three or more nephrology encounters were sensitivity, 96% (95% CI, 94% to 97%); specificity, 93% (95% CI, 91% to 94%); positive predictive value (PPV), 89% (95% CI, 86% to 91%); negative predictive value, 97% (95% CI, 96% to 98%); and area under the receiver operating characteristics curve, 94% (95% CI, 93% to 95%). Requiring that the sum of nephrotic syndrome diagnosis codes exceed that of glomerulonephritis codes identified children with nephrotic syndrome or biopsy-based minimal change nephropathy, FSGS, or membranous nephropathy, with 94% sensitivity and 92% PPV. The algorithm identified 6657 children with glomerular disease across PEDSnet, ≥50% of whom were seen within 18 months. **Conclusions**
The authors developed an EHR-based algorithm and demonstrated that it had excellent classification accuracy across PEDSnet. This tool may enable faster identification of cohorts of pediatric patients with glomerular disease for observational or prospective studies.

Data Source

PEDSnet Nephrology Data Insights
Created:2025-03
This dashboard provides clinical insights into cohorts identified from computable phenotypes for several populations of patients with childhood kidney disease.

#### **Access the PEDSnet Nephrology Data Insights application [here](https://pedsnet.org/ndi/).**

Related Phenotype

Related Person

Related Concept Set

Related Code

Creative Commons license

a CC-BY Attribution 4.0 License.
Except where otherwised noted, this item's license is described as a CC-BY Attribution 4.0 License.